US Stem Cell Inc (USRM)
0.00
USD |
OTCM |
May 17, 16:00
US Stem Cell Shareholders Equity (Quarterly): -14.75M for Dec. 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | -14.75M |
September 30, 2022 | -14.20M |
June 30, 2022 | -13.86M |
March 31, 2022 | -13.37M |
December 31, 2021 | -12.77M |
September 30, 2021 | -12.34M |
June 30, 2021 | -11.89M |
March 31, 2021 | -11.13M |
December 31, 2020 | -11.58M |
September 30, 2020 | -11.18M |
June 30, 2020 | -10.21M |
March 31, 2020 | -9.839M |
December 31, 2019 | -9.479M |
September 30, 2019 | -9.114M |
June 30, 2019 | -7.676M |
March 31, 2019 | -7.096M |
December 31, 2018 | -6.882M |
September 30, 2018 | -7.039M |
June 30, 2018 | -7.042M |
March 31, 2018 | -6.400M |
December 31, 2017 | -7.100M |
September 30, 2017 | -7.536M |
June 30, 2017 | -7.137M |
March 31, 2017 | -7.515M |
December 31, 2016 | -8.019M |
Date | Value |
---|---|
September 30, 2016 | -8.74M |
June 30, 2016 | -7.628M |
March 31, 2016 | -7.688M |
December 31, 2015 | -7.721M |
September 30, 2015 | -8.719M |
June 30, 2015 | -9.160M |
March 31, 2015 | -10.88M |
December 31, 2014 | -10.89M |
September 30, 2014 | -10.81M |
June 30, 2014 | -10.41M |
March 31, 2014 | -12.17M |
December 31, 2013 | -13.75M |
September 30, 2013 | -13.65M |
June 30, 2013 | -13.81M |
March 31, 2013 | -14.02M |
December 31, 2012 | -14.60M |
September 30, 2012 | -13.75M |
June 30, 2012 | -12.62M |
March 31, 2012 | -12.20M |
December 31, 2011 | -12.01M |
September 30, 2011 | -12.29M |
June 30, 2011 | -12.69M |
March 31, 2011 | -12.17M |
December 31, 2010 | -12.02M |
September 30, 2010 | -11.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-14.75M
Minimum
Dec 2022
-7.676M
Maximum
Jun 2019
-11.56M
Average
-11.58M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.068M |
Total Liabilities (Quarterly) | 14.81M |